SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
VIA Pharmaceuticals, Inc. Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease